We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

140 hedge funds and large institutions have $1.71B invested in Ironwood Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 45 increasing their positions, 35 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 35

12% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 17

1% more funds holding

Funds holding: 138 → 140 (+2)

12% less capital invested

Capital invested by funds: $1.93B → $1.71B (-$226M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

58% less call options, than puts

Call options by funds: $3.06M | Put options by funds: $7.37M

Holders
140
Holders Change
+2
Holders Change %
+1.45%
% of All Funds
4.06%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
19
Increased
45
Reduced
35
Closed
17
Calls
$3.06M
Puts
$7.37M
Net Calls
-$4.31M
Net Calls Change
-$6.89M

Top Buyers

Rank Fund Capital Flow
1
JHIU
Janus Henderson Investors US
Colorado
+$92.6M
2
O
OrbiMed
New York
+$42M
3
Deutsche Bank
Deutsche Bank
Germany
+$19.9M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$17.7M
5
Asset Management One
Asset Management One
Japan
+$12.2M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$49.4M
2
Millennium Management
Millennium Management
New York
-$27.8M
3
OIM
Oracle Investment Management
Connecticut
-$24.8M
4
TI
Turner Investments
Pennsylvania
-$11.8M
5
TCM
Tamarack Capital Management
California
-$11.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
TA
51
Teachers Advisors
New York
$2.35M – – –
PAM
52
Paradigm Asset Management
New York
$2.34M +$2.47M +215,875 New
HHC
53
Hutchin Hill Capital
New York
$2.27M – – –
EAM
54
EverPoint Asset Management
Connecticut
$2.27M +$137K +11,940 +6%
BCB
55
Brian C. Broderick
$2.16M – – –
Allianz Asset Management
56
Allianz Asset Management
Germany
$2M – – –
WMSA
57
Weiss Multi-Strategy Advisers
New York
$1.94M -$68.3K -5,970 -3%
Wells Fargo
58
Wells Fargo
California
$1.79M +$1.11M +96,668 +142%
NFA
59
Nationwide Fund Advisors
Ohio
$1.72M +$3.31K +289 +0.2%
Swiss National Bank
60
Swiss National Bank
Switzerland
$1.63M – – –
PIM
61
Platinum Investment Management
Australia
$1.55M – – –
Susquehanna International Group
62
Susquehanna International Group
Pennsylvania
$1.46M +$773K +67,544 +101%
ProShare Advisors
63
ProShare Advisors
Maryland
$1.42M -$288K -25,123 -16%
PWP
64
Private Wealth Partners
California
$1.41M -$80.5K -7,032 -5%
BA
65
BlackRock Advisors
Delaware
$1.33M -$123K -10,787 -8%
RhumbLine Advisers
66
RhumbLine Advisers
Massachusetts
$1.26M -$5.95K -520 -0.4%
MLICM
67
Metropolitan Life Insurance Company (MetLife)
New York
$1.2M – – –
American Century Companies
68
American Century Companies
Missouri
$1.14M +$54K +4,721 +5%
State Board of Administration of Florida Retirement System
69
State Board of Administration of Florida Retirement System
Florida
$1.12M – – –
Mirae Asset Global Investments
70
Mirae Asset Global Investments
South Korea
$1.07M +$1.13M +98,992 New
BACM
71
Blue Arrow Capital Management
New York
$1.04M +$1.1M +95,986 New
AIG
72
American International Group
New York
$1.03M +$19.5K +1,704 +2%
DekaBank Deutsche Girozentrale
73
DekaBank Deutsche Girozentrale
Germany
$915K +$28.7K +2,507 +3%
BG
74
BlackRock Group
United Kingdom
$882K +$257K +22,447 +38%
CS
75
Credit Suisse
Switzerland
$866K -$8.07M -704,880 -90%
1 2
3
4 5

IRWD Hedge Fund Activity: Q3 2014 in Review

140 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q3 2014, worth a combined $1.71B — down 12% from $1.93B a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new IRWD positions and 17 closed out — a net gain of 2 holders — while 45 added to existing stakes and 35 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $92.6M. The largest seller was BVF Inc, cutting an estimated $49.4M.

  • 140 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q3 2014, up from 138 in Q2 2014.
  • Funds reported $1.71B of Ironwood Pharmaceuticals stock for Q3 2014, down 12% quarter-over-quarter.
  • 19 funds opened new Ironwood Pharmaceuticals positions in Q3 2014 and 17 closed out, a net change of +2 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q3 2014 was Janus Henderson Investors US, an estimated $92.6M added.
  • The largest Ironwood Pharmaceuticals seller in Q3 2014 was BVF Inc, an estimated $49.4M sold.

Based on aggregated 13F filings for Q3 2014.